This case demonstrates the feasibility and procedural success of a novel supra-annular transcatheter mitral valve, the AltaValve via transapical approach in a patient with severe symptomatic mitral regurgitation who was a prohibitive surgical risk candidate. ( Level of Difficulty: Advanced. )
Sorry to alarm anyone, but this may save your life (and your family’s life). This issue was in a recent recall, and our VIN number…
One of the major issues encountered in patients undergoing evaluation for Transcatheter mitral valve replacement (TMVR) is the risk of Left ventricular outflow tract (LVOT)…
AbstractBackground. Intracardiac masses are historically treated with surgery. As percutaneous technologies continue to evolve, non-surgical techniques for
Countdown to Innovation: 2024 Asia Pacific Symposium on Structural Heart Disease The 2024 Asia Pacific Symposium on Structural Heart Disease…
Houston Methodist performed its first TAVR surgery on a pregnant woman who needed a new heart valve due to severe aortic stenosis.
AbstractBackgroundLeft ventricular outflow tract (LVOT) obstruction is a source of morbidity in hypertrophic cardiomyopathy (HCM) and a life-threatening complication of transcatheter mitral (TMVR) …
Correspondence to: Neal S. Kleiman, MD, 6565 Fannin, MS WT-4-3020, Houston, TX 77030. Email Houston Methodist DeBakey Heart and Vascular Center, Houston, TX. Houston Methodist…
Tricuspid transcatheter edge-to-edge repair (T-TEER) has emerged as a safe and effective therapy for patients with severe tricuspid regurgitation (TR).1 In The Trial to Evaluate…
Mitral transcatheter edge-to-edge repair (TEER) has proven to be a safe and effective treatment option in patients with primary mitral regurgitation (MR) at high or…
AbstractBackground and Aims. Residual leaks are not infrequent after left atrial appendage occlusion. However, there is still uncertainty regarding their progno
